AstraZeneca PLC (AZN)
NYSE: AZN · Real-Time Price · USD
178.71
+1.44 (0.81%)
At close: Jun 16, 2026, 4:00 PM EDT
179.74
+1.03 (0.58%)
After-hours: Jun 16, 2026, 7:57 PM EDT

AstraZeneca Stock Forecast

Stock Price Forecast

According to 10 analysts polled by S&P Global, AstraZeneca stock has a consensus rating of "Strong Buy" and an average price target of $224.49. The average 1-year stock price forecast is 25.62% higher than the current stock price, while the lowest is $184 (+2.96%) and the highest is $245 (+37.09%).

Price Target: $224.49 (+25.62%)
Analyst Consensus: Strong Buy
TargetLowAverageMedianHigh
Price$184$224.49$226.45$245
Change+2.96%+25.62%+26.71%+37.09%

Analyst Ratings

The average analyst rating for AstraZeneca stock is "Strong Buy". This means that analysts believe this stock is likely to perform very well in the near future and significantly outperform the market.

Recommendation Trends

RatingFeb '26Mar '26Apr '26May '26Jun '26
Strong Buy66777
Buy22222
Hold01111
Sell10000
Strong Sell00000
Total99101010

Latest Forecasts

AnalystFirmRatingRatingActionPrice TargetUpsideDate
Goldman Sachs
Goldman Sachs
Buy
Maintains
$221
BuyMaintains$221+23.67%Jun 10, 2026
Barclays
Barclays
Buy
Maintains
$221
BuyMaintains$221+23.48%Jun 10, 2026
J.P. Morgan
J.P. Morgan
Buy
Maintains
$214
BuyMaintains$214+19.74%Jun 9, 2026
Bank of America Securities
Bank of America Securities
Buy
Reiterates
$221
BuyReiterates$221+23.48%Jun 9, 2026
Deutsche Bank
Deutsche Bank
Sell
Maintains
$154
SellMaintains$154-13.94%Jun 9, 2026
More Analyst Ratings

Financial Forecast

Revenue This Year
63.32B
from 58.74B
Increased by 7.80%
Revenue Next Year
67.16B
from 63.32B
Increased by 6.05%
EPS This Year
10.31
from 9.16
Increased by 12.51%
EPS Next Year
11.63
from 10.31
Increased by 12.81%
Fiscal YearFY 2021FY 2022FY 2023FY 2024FY 2025FY 2026
Period EndingDec 31, 2021Dec 31, 2022Dec 31, 2023Dec 31, 2024Dec 31, 2025Dec 31, 2026
Revenue
37.42B44.35B45.81B54.07B58.74B63.32B
Revenue Growth
40.58%18.53%3.29%18.04%8.63%7.80%
Gross Profit
25.41B35.71B37.77B44.44B47.99B52.04B
Gross Margin
67.92%80.52%82.44%82.18%81.71%82.18%
Operating Income
2.90B8.81B9.70B12.93B14.29B21.24B
Net Income
112.00M3.29B5.96B7.04B10.23B12.43B
EPS
----9.1610.31
EPS Growth
----11.57%12.51%
Forward PE
-----17.34
Dividend / Share
2.872.902.903.103.203.34
Dividend Growth
-1.05%-6.90%3.23%4.27%
Free Cash Flow
-1.85B12.49B9.04B8.46B7.87B10.43B
No. Analysts
-----24
EPS and Forward PE are based on non-GAAP adjusted numbers.

Revenue Forecast

Revenue202620272028
High64.8B
Avg63.3B
Low59.3B

Revenue Growth

Revenue Growth202620272028
High
10.4%
Avg
7.8%
Low
0.9%

EPS Forecast

EPS202620272028
High10.82
Avg10.31
Low10.06

EPS Growth

EPS Growth202620272028
High
18.1%
Avg
12.5%
Low
9.8%